GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...
An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...